375 related articles for article (PubMed ID: 10321595)
1. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
3. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
4. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriasis with polyethylene sheet bath PUVA.
Streit V; Wiedow O; Christophers E
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
8. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
Shephard SE; Schregenberger N; Dummer R; Panizzon RG
Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
[TBL] [Abstract][Full Text] [Related]
10. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity.
Gómez MI; Azaña JM; Arranz I; Harto A; Ledo A
Br J Dermatol; 1995 Jul; 133(1):37-40. PubMed ID: 7669638
[TBL] [Abstract][Full Text] [Related]
12. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
Collins P; Rogers S
Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
[TBL] [Abstract][Full Text] [Related]
14. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
[TBL] [Abstract][Full Text] [Related]
15. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
16. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy.
Schempp CM; Müller H; Czech W; Schöpf E; Simon JC
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):733-7. PubMed ID: 9146535
[TBL] [Abstract][Full Text] [Related]
18. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]